ALARUM TECHNOLOGIES LTD (ALAR)
Immediate Report
Immediate Report
1stDibs to Participate in Upcoming Investor Conference
Smith Micro Reports Second Quarter 2026 Financial Results
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results
CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results
Zoetis - Zoetis Receives Emergency Use Authorization for SimparicaTrio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
Barings Participation Investors Reports Preliminary Second Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.37 Per Share
Barings Corporate Investors Reports Preliminary Second Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.40 Per Share